Article Text

Download PDFPDF
P-024 Scepter C™ Balloon Occlusion Device use for Liquid Embolisation of Vascular Malformations, a Pilot Study
  1. S Grupke1,
  2. A Alhajeri2,
  3. J Fraser1
  1. 1Neurosurgery, University of Kentucky, Lexington, KY
  2. 2Radiology, University of Kentucky, Lexington, KY


Objective The Scepter C™ balloon occlusion catheter (Microvention, Tustin CA) is an endovascular device designed with a polyurethane balloon that elongates with inflation to allow it to conform to the lumen of the target vessel. The device has a double lumen, allowing passage over a 0.014-inch guidewire, and/or passage of Onyx embolisation distal to the balloon. We reviewed our initial use of this device as a conduit for liquid embolisation of vascular malformations as compared to the Marathon™ microcatheter (ev3, Plymouth, MN) alone, outlining indications for and outcomes with use.

Methods We performed a retrospective review of patients who underwent Onyx embolisation of an arterovenous malformation or a dural A-V fistula from October 2011 to February 2013 at the University of Kentucky Hospital.

Results 14 Scepter C™ devices were used in 8 patients over the course of 10 endovascular interventions. We compared this to 8 patients treated with 11 embolisations over the course of 9 interventions without balloon assistance. Technical success was achieved in 13/14 (93%) deployments of the balloon. There were no complications related to Scepter C™ use. Scepter C™ permitted distal navigation, while facilitating faster Onyx injection with more extensive and distal casting. This led to a trend of decreased fluoro time per embolisation with Scepter C™, though not statistically significant (23.0 ± 8.8 min vs 34.0 ± 10.4 min). There were no cases of Onyx fixation of the device in the parent artery; no significant tension was required to remove the device after Onyx injection. This represents a significantly different experience from the typically used Onyx microcatheter (Marathon), which carries a known risk of tip-adhesion to the Onyx cast. We detail technical nuances used to maximise the benefits of the Scepter C™ for such applications.

Conclusions The Scepter C balloon catheter has, thus far, proven to be a safe and effective device for the endovascular treatment of vascular malformations through Onyx embolisation. A larger prospective study should be undertaken to ascertain any potential advantages or disadvantages compared to the current standard delivery catheters.

Disclosures S. Grupke: None. A. Alhajeri: None. J. Fraser: None.

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.